Azmi Nabulsi
2020
In 2020, Azmi Nabulsi earned a total compensation of $2.4M as Chief Operating Officer at Phathom Pharmaceuticals, a 345% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $268,281 |
---|---|
Option Awards | $1,314,243 |
Salary | $445,065 |
Stock Awards | $322,000 |
Other | $14,625 |
Total | $2,364,214 |
Nabulsi received $1.3M in option awards, accounting for 56% of the total pay in 2020.
Nabulsi also received $268.3K in non-equity incentive plan, $445.1K in salary, $322K in stock awards and $14.6K in other compensation.
Rankings
In 2020, Azmi Nabulsi's compensation ranked 4,797th out of 13,090 executives tracked by ExecPay. In other words, Nabulsi earned more than 63.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,797 | 63rd |
Manufacturing | 1,952 | 65th |
Chemicals And Allied Products | 767 | 66th |
Drugs | 660 | 66th |
Pharmaceutical Preparations | 499 | 66th |
Nabulsi's colleagues
We found two more compensation records of executives who worked with Azmi Nabulsi at Phathom Pharmaceuticals in 2020.
News
Phathom Pharmaceuticals CEO Terrie Curran's 2023 pay falls 32% to $3.4M
April 12, 2024
Phathom Pharmaceuticals CEO Terrie Curran's 2022 pay slips 20% to $5M
April 13, 2023
Phathom Pharmaceuticals CEO Terrie Curran's 2020 pay jumps 34% to $4.6M
April 6, 2021
Phathom Pharmaceuticals CEO Terrie Curran receives $3.5M in 2019
April 8, 2020